(Q38488635)

English

Development of a conceptual model evaluating the humanistic and economic burden of Crohn's disease: implications for patient-reported outcomes measurement and economic evaluation

scientific article published on 17 May 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

Europe PubMed Central

Development of a conceptual model evaluating the humanistic and economic burden of Crohn's disease: implications for patient-reported outcomes measurement and economic evaluation (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Crohn's disease

1 reference

based on heuristic

inferred from title

author name string

Adam Gater

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Helen Kitchen

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Louise Heron

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Catherine Pollard

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jonas Håkan-Bloch

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Lise Højbjerre

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Brian Bekker Hansen

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Martin Strandberg-Larsen

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

17 May 2015

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Expert Review of Pharmacoeconomics & Outcomes Research

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

643-656

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Disease activity courses in a regional cohort of Crohn's disease patients.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Review article: infliximab for Crohn's disease treatment--shifting therapeutic strategies after 10 years of clinical experience

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

The quality of life in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Cost of illness of Crohn's disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Annual cost of care for Crohn's disease: a payor perspective.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Guidelines for the management of inflammatory bowel disease in adults

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Advances in the management of Crohn's disease: economic and clinical potential of infliximab.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

"Mind the Gap": an unmet need for new therapy in IBD.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO in

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients' organization: a patient empowerment study

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Effects of fistula on healthcare costs and utilization for patients with Crohn's disease treated in a managed care environment.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

The experience of fatigue in people with inflammatory bowel disease: an exploratory study

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Health determining concepts important to people with Crohn's disease and their coverage by patient-reported outcomes of health and wellbeing

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Unemployment and disability in patients with moderately to severely active Crohn's disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Health-related quality of life during natalizumab maintenance therapy for Crohn's disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Is there any food I can eat? Living with inflammatory bowel disease and/or irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

I am doing the best that I can!: Living with inflammatory bowel disease and/or irritable bowel syndrome (part II).

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Impaired sleep quality in Crohn's disease depends on disease activity

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

A population-based study of fatigue and sleep difficulties in inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: ten-year results from the IBSEN study

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Medication adherence and quality of life in pediatric inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

A qualitative study of youth living with Crohn disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Inflammatory bowel disease: a patient's and caregiver's perspective.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Quality of life in perianal Crohn's disease: what do patients consider important?

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Patient perspectives on the impact of Crohn's disease: results from group interviews

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

The burden of inflammatory bowel disease on health care utilization and quality of life

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Fatigue interference with daily living among patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

The importance of illness perceptions, quality of life and psychological status in patients with ulcerative colitis and Crohn's disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Impact of pain on health-related quality of life in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Worries and concerns in a large unselected cohort of patients with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Crohn's disease: a patient's perspective.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

The direct and indirect cost burden of Crohn's disease and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Capsule endoscopy in suspected small bowel Crohn's disease: economic impact of disease diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Resource use and societal costs for Crohn's disease in Sweden.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Health care costs and their predictors of inflammatory bowel diseases in Germany.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Costs of care for Crohn's disease following the introduction of infliximab: a single-centre UK experience

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Costs of inflammatory bowel disease in Germany

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

The costs of Crohn's disease in the United States and other Western countries: a systematic review

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Disease perceptions among people with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Infliximab use in Crohn's disease: impact on health care resources in the UK.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

EQ-5D: a measure of health status from the EuroQol Group

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Development and validation of the Crohn's disease perceived work disability questionnaire

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Systematic review of health-related quality of life measures for inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

The burden of inflammatory bowel disease: a patient-reported qualitative analysis and development of a conceptual model

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Assessment of PRO label claims granted by the FDA as compared to the EMA (2006-2010)

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Cost-effectiveness of nucleoside analog therapy for hepatitis B in China: a Markov analysis

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-control questionnaire

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

The inflammatory bowel disease questionnaire: a review of its national validation studies

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

A new validation of the Spanish Work Productivity and Activity Impairment Questionnaire-Crohn's disease version

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Validation of the Spanish Work Productivity and Activity impairment questionnaire: Crohn's disease version.

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohnʼs disease

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2015.1045883

21 January 2018

Identifiers

10.1586/14737167.2015.1045883

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38488635&oldid=1761990022"